Antimicrobials and Vaccines

Definition: The spectrum of activity refers to the range of bacteria that an antibiotic can effectively target. Antibiotics can be classified as broad-spectrum or narrow-spectrum based on the variety of pathogens they can affect.

Use Case: Broad-spectrum antibiotics are favored in life-threatening infections where the specific causative agent is unknown. Their ability to target a wide array of bacteria makes them suitable for empirical therapy until the pathogen is identified.
Examples: Drugs like tetracyclines and amoxicillin are considered broad-spectrum.

Benefits: Narrow-spectrum antibiotics specifically target certain bacteria, which helps in reducing the disruption to the gut microbiome and decreases the chances of developing antibiotic resistance. They are often preferred once the pathogen is identified.
Examples: Penicillin is a classic example of a narrow-spectrum antibiotic primarily effective against Gram-positive bacteria.

Bactericidal Antibiotics: These kill bacteria directly and are preferred for serious infections or in immunocompromised patients where the immune system may not effectively eliminate the pathogen. Examples include penicillin and cephalosporins.
Bacteriostatic Antibiotics: These inhibit bacterial growth and rely on the immune system to clear the infection. They are often used for milder infections. Examples include macrolides and tetracyclines.

Definition: Selective toxicity refers to the antibiotic's ability to target bacterial processes or structures without harming human cells. This is crucial for minimizing side effects.
Measure: The therapeutic index (TI), which is the ratio of the toxic dose to the therapeutic dose, serves as a measure of selective toxicity. A higher TI indicates a safer antibiotic.

Definition: The therapeutic window is the range between the minimal effective dose and the toxic dose of a drug. It is determined through clinical testing to ensure safety and efficacy.

Consideration: In patients undergoing kidney dialysis, the half-life of medications is critical because impaired kidney function can lead to drug accumulation and toxicity. Medications with a long half-life may need to be avoided or adjusted in dosage.

Common Structure: The most prevalent cell wall inhibitors share a common structure known as the β-lactam ring.
First Inhibitor Discovered: Penicillin was the first discovered inhibitor of cell wall synthesis, revolutionizing the treatment of bacterial infections.
Spectrum of Activity: First-generation cell wall inhibitors typically have a narrow spectrum, primarily effective against Gram-positive bacteria.
Therapeutic Window: Most cell wall inhibitors exhibit a large therapeutic window, except for glycopeptides like vancomycin, which have a narrow therapeutic window, requiring close monitoring.

Unpredictable Toxicity: Inhibitors of protein synthesis can be unpredictable in terms of toxicity because they may also interact with mitochondrial ribosomes, which are similar to bacterial ribosomes.
Safety Profile: Macrolides are considered the safest inhibitors of protein synthesis, whereas aminoglycosides are the most dangerous due to significant toxic effects, including kidney and ear damage. Tetracyclines possess the broadest spectrum of activity among protein synthesis inhibitors.

Diversity of Action: The diverse mechanisms of nucleic acid synthesis inhibitors arise from their ability to target multiple steps in DNA and RNA metabolism, including replication and transcription.

Mechanism: Most antimetabolites function as bacteriostatic agents by competitively inhibiting critical metabolic pathways, effectively halting bacterial growth.

Topical Use: The majority of cell membrane inhibitors are only suitable for topical use due to their potential toxicity to human cells, as they indiscriminately damage cell membranes.

Antibiotic-Inactivating Enzymes: Enzymes produced by bacteria that can degrade or modify the antibiotic.
Alteration in Target Molecule: Changes in the antibiotic's target within the bacterial cell, preventing the drug from binding effectively.
Decreased Uptake of Medication: Reduced permeability of the bacterial cell wall, leading to lower drug concentrations inside the bacteria.
Increased Elimination of Medication: Efflux pumps can expel the antibiotic from the bacterial cell before it can exert its effect.

Mechanisms: Bacteria can acquire resistance through spontaneous mutations or by horizontal gene transfer, often via plasmids, allowing them to share resistant traits with other bacteria.

B Cell Response: A B cell response is the favored response for vaccines because B cells produce antibodies, which provide long-lasting immunity and memory responses.
Lives Saved by Vaccines: It is estimated that vaccines save 2-3 million lives annually, while around 1.5-2 million people still die from vaccine-preventable diseases each year.
Severe Reactions to Vaccines: The chances of a severe reaction to vaccines are exceedingly low, at less than 1 in 1,000,000.
Measles Mortality Rate: The fatality rate for measles is about 6 in 1,000 pediatric cases.

Attenuated Vaccines: These use weakened live pathogens that stimulate a strong immune response but carry risks for immunocompromised individuals due to potential reversion to virulence.
Inactivated Vaccines: Composed of inactivated pathogens, these vaccines eliminate the risk of infection but often provoke a weaker immune response compared to live vaccines.
Recombinant Vaccines: These are produced via genetic engineering to create antigens that can induce an immune response, like the Hepatitis B vaccine.
RNA Vaccines: They provide genetic instructions to produce an antigen, provoking an immune response but may not be effective for long-term immunity without further development.